Inferring tumour purity and stromal and immune cell admixture from expression data
Open accessThe DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Abstract
Infiltrating stromal and immune cells form the major fraction of normal cells in tumour tissue and not only perturb the tumour signal in molecular studies but also have an important role in cancer biology. Here we describe ‘Estimation of STromal and Immune cells in MAlignant Tumours using Expression data’ (ESTIMATE)—a method that uses gene expression signatures to infer the fraction of stromal and immune cells in tumour samples. ESTIMATE scores correlate with DNA copy number-based tumour purity across samples from 11 different tumour types, profiled on Agilent, Affymetrix platforms or based on RNA sequencing and available through The Cancer Genome Atlas. The prediction accuracy is further corroborated using 3,809 transcriptional profiles available elsewhere in the public domain. The ESTIMATE method allows consideration of tumour-associated normal cells in genomic and transcriptomic studies. An R-library is available on https://sourceforge.net/projects/estimateproject/ . Tumour biopsies contain contaminating normal cells and these can influence the analysis of tumour samples. In this study, Yoshihara et al.develop an algorithm based on gene expression profiles from The Cancer Genome Atlas to estimate the number of contaminating normal cells in tumour samples.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“this result is not merely a reflection of the extent of immune infiltration, as indicated by the lack of correlation between the γδ T cell signature score and ESTIMATE (Yoshihara et al., 2013) immune signature score for individual patients”
From Commensal Microbiota Promote Lung Cancer Development via γδ T Cells (2019) · cites this paper as Yoshihara et al., 2013
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
R: A Language and Environment for Statistical Computing
R Core Team (2025) · doi:10.32614/r.manuals · Cited by 352,181
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590 · cited 2×
“We devised two gene signatures: (1) a ‘stromal signature’ that was designed to capture the presence of stroma in tumour tissue, and (2) an ‘immune signature’ that aimed to represent the infiltration of immune cells in tumour tissue (Supplementary Data 1).”
MethodRSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome
Li, B., & Dewey, C. N. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-323 · Cited by 22,179
pROC: an open-source package for R and S+ to analyze and compare ROC curves
Robin, X., Turck, N., Hainard, A., Tiberti, N., Lisacek, F., Sanchez, J.-C., & Müller, M. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-77 · Cited by 13,697
Mapping and quantifying mammalian transcriptomes by RNA-Seq
Mortazavi, A., Williams, B. A., McCue, K., Schaeffer, L., & Wold, B. (2008) · Nature Methods · doi:10.1038/nmeth.1226 · Cited by 13,696
Gene Expression Omnibus: NCBI gene expression and hybridization array data repository
Edgar, R. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.207 · Cited by 13,288
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
In silico prediction of protein-protein interactions in human macrophages
Souiai, O., Guerfali, F., Ben Miled, S., Brun, C., & Benkahla, A. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-157 · Cited by 10,803
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Cited by
Items 701–800 of 1,021
Classification of diffuse lower‐grade glioma based on immunological profiling
Wu, F., Wang, Z., Wang, K., Li, G., Chai, R., Liu, Y., Jiang, H., Zhai, Y., Feng, Y., Zhao, Z., et al. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12707 · Cited by 63
“We computed stromal and immune scores based on the ESTIMATE method (Yoshihara et al., 2013).”
MethodHu, Z., Chen, L., Ma, R., Wei, F., Wen, Y., Zeng, X., Sun, W., & Wen, W. (2021) · Aging · doi:10.18632/aging.202841 · Cited by 55
Mattesen, T. B., Rasmussen, M. H., Sandoval, J., Ongen, H., Árnadóttir, S. S., Gladov, J., Martínez‐Cardús, A., de Moura, M. C., Madsen, A. H., Laurberg, S., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16000-6 · Cited by 52
Zhang, H., AbdulJabbar, K., Moore, D. A., Akarca, A. U., Enfield, K. S. S., Jamal‐Hanjani, M., Raza, S. E. A., Veeriah, S., Salgado, R., McGranahan, N., et al. (2023) · Cancer Research · doi:10.1158/0008-5472.can-22-2589 · Cited by 52
“This includeda comparisonbetweencancer &E,andtumorpuritymeasuresfromthegeneexpression-based method ESTIMATE (7) and copy number – based ABSOLUTE (8).”
Wu, C., Tan, J., Shen, H., Deng, C., Kleber, C., Osterhoff, G., & Schopow, N. (2024) · Journal of Biomedical Science · doi:10.1186/s12929-024-00999-7 · Cited by 55
“The ESTIMATE algorithm is a method for inferring the overall level of immune infiltration in tumor tissues based on gene expression data and has been widely used in a large number of previous studies [33, 34].”
MethodSelf-citationDesai, P. A., Takahashi, N., Kumar, R., Nichols, S., Malin, J., Hunt, A. L., Schultz, C. W., Cao, Y., Tillo, D., Nousome, D., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101610 · Cited by 64
Modeling oil production based on symbolic regression
Yang, G., Li, X., Wang, J., Lian, L., & Ma, T. (2015) · Energy Policy · doi:10.1016/j.enpol.2015.02.016 · Cited by 51
Vincent, K. M., & Postovit, L.-M. M. (2017) · Scientific Reports · doi:10.1038/srep42719 · Cited by 51
Integrin Beta 5 Is a Prognostic Biomarker and Potential Therapeutic Target in Glioblastoma
Zhang, L., Guo, Q., Guan, G., Cheng, W., Cheng, P., & Wu, A. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00904 · Cited by 55
“Receiver Operator Characteristic (ROC) Curve The ROC curve was plotted and the area under the ROC curve of each cutoff was determined as previously described (15, 16).”
MethodIntegrated Analysis of Prognostic and Immune Associated Integrin Family in Ovarian Cancer
Wu, A., Zhang, S., Liu, J., Huang, Y., Deng, W., Shu, G., & Yin, G. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00705 · Cited by 52
“After adjustment by tumor purity (Yoshihara et al., 2013), we found ITGA1/A5/A8/A11/AD/AV and ITGB1 showed weakly correlation with macrophage markers in OC, ITGA5/A11 and ITGB5 weakly correlated with Treg markers, ITGAD and ITGB6 showed weakly correlation with natural killer cells markers.”
BackgroundTumor Cell–Derived TGFβ1 Attenuates Antitumor Immune Activity of T Cells via Regulation of PD-1 mRNA
Wu, P., Geng, B., Chen, Q., Zhao, E., Liu, J., Sun, C., Zha, C., Shao, Y., You, B., Zhang, W., et al. (2020) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-20-0113 · Cited by 54
“Briefly, we defined ssGSEA based on the signatures related to stromal tissue and immune cell infiltration as stromal and immune scores, and combined the stromal and immune scores as the ESTIMATE score (15).”
MethodOverexpressed PLAU and its potential prognostic value in head and neck squamous cell carcinoma
Li, Z., Chen, C., Wang, J., Wei, M., Liu, G., Qin, Y., Li, S., Liu, Y., Huang, D., Tian, Y., et al. (2021) · PeerJ · doi:10.7717/peerj.10746 · Cited by 59
Lin, E., Liu, X., Liu, Y., Zhang, Z., Xie, L., Tian, K., Liu, J., & Yu, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.653358 · Cited by 59
Shen, Y., Xu, L., Tang, X., Lin, C., Dong, Y., Song, X., Qian, R., & Guo, D. (2021) · BMC Medical Genomics · doi:10.1186/s12920-021-00991-2 · Cited by 55
“In our study, we first deemed that the ESTIMATE algorithm might be appropriate for assessing the immune infiltration of different plaques because the gene sets used for estimating stromal and immune scores in the ESTIMATE algorithm are filtered by a dataset of gene expression in normal tissues (GSE1133, including smoo…”
MethodTumor purity as a prognosis and immunotherapy relevant feature in cervical cancer
Deng, Y., Song, Z., Huang, L., Guo, Z., Tong, B., Sun, M., Zhao, J., Zhang, H., Zhang, Z., & Li, G. (2021) · Aging · doi:10.18632/aging.203714 · Cited by 58
“In the TME, immune and stroma cells are the main components of normal cells and exert important biological roles in tumor processes [7].”
BackgroundMethodShah, M. A., Cunningham, D., Metges, J., Cutsem, E. V., Wainberg, Z. A., Elboudwarej, E., Lin, K.-W., Turner, S., Zavodovskaya, M., Inzunza, H. D., et al. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-003580 · Cited by 54
Wang, L., Wei, Q., Zhang, M., Chen, L., Li, Z., Zhou, C., He, M., Wei, M., & Zhao, L. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106795 · Cited by 50
Identification of Tumor Antigens and Immune Subtypes of Glioblastoma for mRNA Vaccine Development
Han, L., Wang, K., Xiong, Y., Zhou, L., Yang, Y., Chen, S., Xu, P., Zhou, Y., Mao, R., Lv, G., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.773264 · Cited by 53
An Integrative Human Pan-Cancer Analysis of Cyclin-Dependent Kinase 1 (CDK1)
Liu, X., Wu, H., & Liu, Z. (2022) · Cancers · doi:10.3390/cancers14112658 · Cited by 51
“A lower ImmuneScor or StromalScore indicates a lower percentage of immun cells r st o al cells in the core and the invasive margin of the tumor [26].”
BackgroundDing, R., Prasanna, P., Corredor, G., Barrera, C., Zens, P., Lu, C. Y., Velu, P., Leo, P., Beig, N. G., Li, H., et al. (2022) · npj Precision Oncology · doi:10.1038/s41698-022-00277-5 · Cited by 54
Gu, X., Huang, X., Zhang, X., & Wang, C. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.75284 · Cited by 57
“The estimate algorithm was used to assess the immunological activity and tumor purity of the samples [15].”
MethodHuang, Y., Yin, D., & Wu, L. (2022) · Scientific Reports · doi:10.1038/s41598-022-22300-2 · Cited by 58
Golkaram, M., Kuo, F., Gupta, S., Carlo, M. I., Salmans, M., Vijayaraghavan, R., Tang, C., Makarov, V., Rappold, P. M., Blum, K. A., et al. (2022) · Genome Medicine · doi:10.1186/s13073-022-01146-3 · Cited by 51
“ESTIMATE The ESTIMATEScore, which is the estimate of the presence of stromal and immune cells in tumor tissue, is calculated through the ESTIMATE R package [22] based on a given gene expression profile in FPKM.”
MethodYang, X., Chen, X., Zhang, S., Fan, W., Zhong, C., Liu, T., Cheng, G., ZHU, L. B., Liu, Q., Xi, Y., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113270 · Cited by 53
Xie, T., Peng, S., Liu, S., Zheng, M., Diao, W., Ding, M., Fu, Y. S., Guo, H., Zhao, W., & Zhuang, J. (2024) · Molecular Cancer · doi:10.1186/s12943-024-01945-9 · Cited by 53
“The ESTIMATE (Estimation of Stromal and Immune cells in Malignant Tumor tissues using Expression data) algorithm assessed variations in the immune score, stromal score, ESTIMATE score, and tumor purity among samples [29].”
MethodLiu, Z., Wu, Y., Xu, H., Wang, M., Weng, S., Pei, D., Chen, S., Wang, W., Yan, J., Cui, L., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-58675-9 · Cited by 54
Liu, J., Zhang, W., Chen, L., Wang, X., Mao, X., Wu, Z., Shi, H., Qi, H., Chen, L., Huang, Y., et al. (2025) · Clinical and Translational Medicine · doi:10.1002/ctm2.70340 · Cited by 60
Cantariño, N., Musulén, E., Valero, V., Peinado, M. A., Perucho, M., Moreno, V. R., Forcales, S. V., Douet, J., & Buschbeck, M. (2016) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0034 · Cited by 52
“We have further used the R-package "estimate" (36) to infer an immune score that seemed unrelated to PADI2 expression (Supplementary Fig.”
MethodValidation of a hypoxia related gene signature in multiple soft tissue sarcoma cohorts
Yang, L., Forker, L. J., Irlam, J. J., Pillay, N., Choudhury, A., & West, C. (2017) · Oncotarget · doi:10.18632/oncotarget.23280 · Cited by 51
“The ESTIMATE [21] computational algorithm was used to evaluate the presence of tumor-infiltrating immune cells.”
MethodInfluentialTOBMI: trans-omics block missing data imputation using a k-nearest neighbor weighted approach
Dong, X., Lin, L., Zhang, R., Zhao, Y., Christiani, D. C., Wei, Y., & Chen, F. (2019) · Bioinformatics · doi:10.1093/bioinformatics/bty796 · Cited by 49
de Almeida, B. P., Vieira, A. F., Paredes, J., Bettencourt‐Dias, M., & Barbosa‐Morais, N. L. (2019) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1006832 · Cited by 50
Immunophenotypes of pancreatic ductal adenocarcinoma: Meta‐analysis of transcriptional subtypes
de Santiago, I., Yau, C., Heij, L. R., Middleton, M. R., Markowetz, F. M., Grabsch, H. I., Dustin, M. L., & Sivakumar, S. (2019) · International Journal of Cancer · doi:10.1002/ijc.32186 · Cited by 53
“that change in response to signals from the tumour cells, and innate and adaptive immune system cells.(3,4) Several recent studies have described the transcriptomic land-”
BackgroundMethodIdentification of prognostic genes in the acute myeloid leukemia microenvironment
Huang, S., Zhang, B., Fan, W., Zhao, Q., Yang, L., Xin, W., & Fu, D. (2019) · Aging · doi:10.18632/aging.102477 · Cited by 55
“Gene expression profiles from AML patients were downloaded from TCGA database, and immune and stromal scores were calculated using the ESTIMATE algorithm.”
MethodInfluentialBiological Landscape of Triple Negative Breast Cancers Expressing CTLA-4
Navarrete-Bernal, M. G. C., Cervantes-Badillo, M. G., Martínez‐Herrera, J. F., Lara-Torres, C. O., Gerson-Cwilich, R., Zentella‐Dehesa, A., Ibarra-Sánchez, M. D. J., Esparza‐López, J., Montesinos, J. J., Cortés-Morales, V. A., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01206 · Cited by 55
“Tumor Purity Tumor purity was inferred according to the ESTIMATE algorithm (28).”
MethodLi, N., Wang, J., & Zhan, X. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.752643 · Cited by 57
“Immune Cell Infiltration Abundance The single-sample Gene Set Enrichment Analysis (ssGSEA) was used to quantify the abundance of TME immune cell infiltration with GSEABase R package based on RNA-seq gene expression data (21).”
BackgroundInfluentialZeng, Q., Zhang, W., Li, X., Lai, J., & Li, Z. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117273 · Cited by 49
Liu, J., Nie, S., Wu, Z., Jiang, Y., Wan, Y., Li, S., Meng, H., Zhou, S., & Cheng, W. (2020) · Genomics · doi:10.1016/j.ygeno.2020.05.022 · Cited by 55
Zhang, N., Zhang, H., Wang, Z., Dai, Z., Zhang, X., Cheng, Q., & Liu, Z. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.691811 · Cited by 63
“Infiltration level of stromal cells and immune cells in glioma samples was assessed using the consensus ESTIMATE (Estimation of Stromal and Immune cells in Malignant Tumor tissues using Expression) algorithm (18).”
MethodZhang, W., Shi, F., Kong, Y., Li, Y., Sheng, C., Wang, S., & Wang, Q. (2021) · Cancer Medicine · doi:10.1002/cam4.4472 · Cited by 59
Wei, E., Reisinger, A., Li, J., French, L. E., Clanner-Engelshofen, B. M., & Reinholz, M. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.860900 · Cited by 49
“Immune Estimate The immune score was estimated using ESTIMATE (Estimation of Stromal and Immune cells in Malignant Tumors using Expression data) (10).”
MethodKhadirnaikar, S., Shukla, S. K., & Prasanna, S. R. M. (2023) · Scientific Reports · doi:10.1038/s41598-023-31426-w · Cited by 54
Xin, H., Lai, Q., Zhou, Y., He, J., Song, Y., Liao, M., Sun, J., Li, M., Zhang, M., Liang, W., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1134521 · Cited by 49
“microenvironment, such as the infiltration level of immune cells (ImmuneScore), and stromal content (StromalScore) (29).”
BackgroundNeoadjuvant Afatinib for stage III EGFR-mutant non-small cell lung cancer: a phase II study
Bian, D., Sun, L., Hu, J., Duan, L., Xia, H., Zhu, X., Sun, F., Zhang, L., Yu, H., Xiong, Y., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40349-z · Cited by 60
“The immune scores of each sample were calculated using the “ ESTI-MATE ” R package 70 .”
Guo, Y., Li, T., Gong, B., Hu, Y., Wang, S., Yang, L., & Zheng, C. (2024) · Advanced Science · doi:10.1002/advs.202408069 · Cited by 62
Dieters‐Castator, D. Z., Rambau, P., Kelemen, L. E., Siegers, G. M., Lajoie, G., Postovit, L.-M. M., & Köbel, M. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-3818 · Cited by 51
“The Estimation of STromal and Immune cells in MAlignant Tumours using Expression data (ESTIMATE) score in R was used as a surrogate to assess epithelial (tumor) cell purity (34).”
MethodEstimation of immune cell content in tumor using single-cell RNA-seq reference data
Yu, X., Chen, Y. A., Conejo-Garcia, J. R., Chung, C. H., & Wang, X. (2019) · BMC Cancer · doi:10.1186/s12885-019-5927-3 · Cited by 53
Deng, Z., Wang, J., Xu, B., Jin, Z., Wu, G., Zeng, J., Peng, M., Guo, Y., & Zhang, W. (2019) · BioMed Research International · doi:10.1155/2019/2408348 · Cited by 51
“Based on the ESTIMATE algorithm, the range of stromal score was from − 1,625.38 to 1,171.12, and the range of immune score was from − 866.31 to 3,146.06.”
MethodInfluentialWei, S., Lu, J., Lou, J., Shi, C., Mo, S., Shao, Y., Ni, J., Zhang, W., & Cheng, X. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00663 · Cited by 62
Wang, Y., Yan, K., Lin, J., Li, J., & Bi, J. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.615655 · Cited by 59
Zeng, B., Glicksberg, B. S., Newbury, P., Chekalin, E., Xing, J., Liu, K., Wen, A., Chow, C., & Chen, B. (2021) · Nature Protocols · doi:10.1038/s41596-020-00430-z · Cited by 48
Liu, X., Niu, X., & Qiu, Z. (2020) · DNA and Cell Biology · doi:10.1089/dna.2020.5512 · Cited by 50
“As in previous studies, using ESTIMATE, stroma/immune cell score has been confirmed to be correlated with prognosis in patients with several tumors (Yoshihara et al. , 2013).”
PDIA5 is Correlated With Immune Infiltration and Predicts Poor Prognosis in Gliomas
Zhang, H., He, J., Dai, Z., Wang, Z., Liang, X., He, F., Xia, Z., Feng, S., Cao, H., Zhang, L., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.628966 · Cited by 62
“ESTIMATE (Estimation of Stromal and Immune cells in Malignant Tumor tissues using Expression) algorithm was performed as previously reported (36) to evaluate the presence of stromal cells and the infiltration of immune cells in tumor samples.”
MethodYang, X., Weng, X., Yang, Y., Zhang, M., Xiu, Y., Peng, W., Liao, X., Xu, M., Sun, Y., & Liu, X. (2021) · Aging · doi:10.18632/aging.203360 · Cited by 52
“immune and stromal components which reflect by immune and stromal scores were estimated using the „estimate‟ package [32].”
MethodLin, A., Qiu, Z., Zhang, J., & Luo, P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.630773 · Cited by 45
“Additionally, we used the ESTIMATE algorithm to calculate the stromal and immune scores and tumor purity of the TCGA-BLCA cohort (24).”
MethodITGA5 Is a Novel Oncogenic Biomarker and Correlates With Tumor Immune Microenvironment in Gliomas
Li, S., Zhang, N., Liu, S., Zhang, H., Liu, J., Qi, Y., Zhang, Q., & Li, X. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.844144 · Cited by 48
“Stromal and Immune cells in Malignant Tumor tissues using Expression (ESTIMATE) algorithm, and reflected by immune score, stromal score, and estimate score separately (19).”
MethodChen, Y., Hong, W., Liu, M., Guo, X., Yu, Y., Cui, Y., Liu, T., & Liang, L. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04692-1 · Cited by 54
“The algorithm in the ESTIMATE package [47] quantified the immunological activity of gene expression profiles and produced the immune score of each tumor sample.”
MethodThe role of tetraspanins pan-cancer
Huang, R., Sun, H., Lin, R., Zhang, J., Yin, H., Xian, S., Li, M., Wang, S., Li, Z., Qiao, Y., et al. (2022) · iScience · doi:10.1016/j.isci.2022.104777 · Cited by 52
Dings, M. P. G., van der Zalm, A. P., Bootsma, S., van Maanen, T., Waasdorp, C., van den Ende, T., Liu, D., Bailey, P. J., Köster, J., Zwijnenburg, D. A., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100802 · Cited by 53
Duan, H., Ren, J., Wei, S., Yang, Z., Li, C., Wang, Z., Li, M., Wei, Z., Liu, Y., Wang, X., et al. (2024) · Genome Medicine · doi:10.1186/s13073-024-01410-8 · Cited by 49
Deep learning based Nucleus Classification in pancreas histological images
Chang, Y. H., Thibault, G., Madin, O., Azimi, V., Meyers, C., Johnson, B., Link, J. M., Margolin, A. A., & Gray, J. W. (2017) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc.2017.8036914 · Cited by 53
“However, recent genomic studies [1] [2] show discrepancy between DNA copy number-based tumor purity and histological tumor purity.”
BackgroundEvolution and structure of clinically relevant gene fusions in multiple myeloma
Foltz, S. M., Gao, Q., Yoon, C. J., Sun, H., Yao, L., Li, Y., Jayasinghe, R. G., Cao, S., King, J. A., Kohnen, D. R., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16434-y · Cited by 61
Yang, H., Sun, L., Guan, A., Yin, H., Liu, M., Mao, X., Xu, H. C., Zhao, H., Lü, X., Sang, X., et al. (2020) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-020-02711-8 · Cited by 50
Comprehensive integrative profiling of upper tract urothelial carcinomas
Su, X., Lu, X., Bazai, S. K., Compérat, É., Mouawad, R., Yao, H., Rouprêt, M., Spano, J., Khayat, D., Davidson, I., et al. (2021) · Genome biology · doi:10.1186/s13059-020-02230-w · Cited by 56
“The presence of infiltrating immune/stromal cells in tumor tissue was estimated by R package ESTIMATE [46].”
MethodLiu, B., Chen, X., Zhan, Y., Wu, B., & Pan, S. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.604627 · Cited by 50
Evaluating the transcriptional fidelity of cancer models
Peng, D., Gleyzer, R., Tai, W.-H., Kumar, P., Bian, Q., Isaacs, B., da Rocha, E. L., Cai, S., DiNapoli, K. T., Huang, F. W., et al. (2021) · Genome Medicine · doi:10.1186/s13073-021-00888-w · Cited by 51
“The data were expressed as means ± SD. Tumor Purity Analysis We used the R package ESTIMATE95 to calculate the ESTIMATE scores from TCGA tumor expression profiles that we used as training data for CCN classifier.”
MethodJia, R., Sui, Z., Zhang, H., & Yu, Z. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.679031 · Cited by 48
Proteotranscriptomic classification and characterization of pancreatic neuroendocrine neoplasms
Yang, K., Kalloger, S. E., Aird, J. J., Lee, M. K. C., Rushton, C. K., Mungall, K. L., Mungall, A. J. J., Gao, D., Chow, C., Xu, J., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109817 · Cited by 51
Blenman, K., Marczyk, M., Karn, T., Qing, T., Li, X., Gunasekharan, V. K., Yaghoobi, V., Bai, Y., Ibrahim, E., Park, T., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-3215 · Cited by 49
Ding, Z., Dong, Z., Chen, Z., Hong, J., Yan, L., Li, H., Yao, S., Yan, Y., Yang, Y., Yang, C., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.733530 · Cited by 47
“The immune score, stromal score, and ESTIMATE score of each single HCC sample were estimated using the ESTIMATE algorithm to validate the effect of ssGSEA immune clustering (24).”
MethodFeng, S., Xia, T., Ge, Y. P., Zhang, K., Ji, X., Luo, S., & Shen, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.868067 · Cited by 52
“The ESTIMATE algorithm (38) was utilized to assess the overall state of the TME (immune score, stromal score, and tumor purity).”
MethodZhang, G., Chen, X., Fang, J., Tai, P., Chen, A., & Cao, K. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.954440 · Cited by 75
“StromalScore and ImmuneScore represent the abundance of stromal and immune components, respectively, whereas ESTIMATEScore is the sum of StromalScore and ImmuneScore, which is negatively correlated with tumor purity (21).”
BackgroundYang, C. G., Zhang, S., Cheng, Z., Liu, Z., Zhang, L., Jiang, K., Geng, H., Qian, R., Wang, J., Huang, X., et al. (2022) · Genome Medicine · doi:10.1186/s13073-022-01143-6 · Cited by 51
“Then, we collected 141 immune genes from previous publication to generate an immune gene expression profile [60].”
MethodImmune microenvironment infiltration landscape and immune-related subtypes in prostate cancer
Wu, W., Wang, X., Le, W., Lu, C., Li, H., Zhu, Y., Chen, X., An, W., Xu, C., Wu, Q., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1001297 · Cited by 50
“The ICI landscape in the TME of PC CIBERSORT and ESTIMATE algorithms in the R package were used to determine the ICI landscape of patients with PC by calculating the immune score, stromal score, and the content of 22 immune cells (Supplementary Table S2) (17, 18).”
MethodInfluentialZhang, T., Zhao, F., Lin, Y., Liu, M., Zhou, H., Cui, F., Jin, Y., Chen, L., & Sheng, X. (2024) · Theranostics · doi:10.7150/thno.92336 · Cited by 52
“R package “estimate” was used to evaluate the stromal score, immune score and tumor purity of each samples using bulk transcription profile data [42].”
MethodResultSibai, M., Cervilla, S., Grases, D., Musulén, E., Lazcano, R., Mo, C.-K., Dávalos, V., Fortian, A., Bernat‐Peguera, A., Romeo, M., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2024.115229 · Cited by 57
Predicting tumor purity from methylation microarray data
Zhang, N., Wu, H., Zhang, W., Wang, J., Wu, H., & Zheng, X. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btv370 · Cited by 51
“Contact: xqzheng@shnu.edu.cn or hao.wu@emory.edu Supplementary information: Supplementary data are available at Bioinformatics online.”
BackgroundWu, H., Yu, J., Li, Y., Hou, Q., Zhou, R., Zhang, N., Zhao, J., Jiang, M., Li, Z., Hua, Y., et al. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.09.017 · Cited by 51
Romero-Cordoba, S. L., Meneghini, E., Sant, M., Iorio, M. V., Sfondrini, L., Paolini, B., Agresti, R., Tagliabue, E., & Bianchi, F. (2019) · Cancers · doi:10.3390/cancers11070911 · Cited by 50
“We then examined the distribution of stromal and immune content per Im-Clus by computing Estimate algorithm [21].”
MethodKnowledge-guided analysis of "omics" data using the KnowEnG cloud platform
Blatti, C. A., Emad, A., Berry, M. J., Gatzke, L., Epstein, M., Lanier, D., Rizal, P., Ge, J., Liao, X., Sobh, O. T., et al. (2020) · PLoS Biology · doi:10.1371/journal.pbio.3000583 · Cited by 54
“Signature analysis [56] is a widely used method in cancer informatics and has been used for various tasks such as identifying subtypes [36], characterizing purity of tumor samples [57], determining the abundance of immune cells in tumor microenvironment [58], characterizing transitions involved in the invasion-metasta…”
Development of an Immune-Related Prognostic Signature in Breast Cancer
Xie, P., Ma, Y., Yu, S., An, R. F., He, J., & Zhang, H. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2019.01390 · Cited by 55
Kan, T., Wang, W., Ip, P. P. C., Zhou, S., Wong, A. S. T., Wang, X., & Yang, M. (2020) · Oncogene · doi:10.1038/s41388-020-1288-2 · Cited by 48
Chen, Y., Wang, C., Song, J., Xu, R., Ruze, R., & Zhao, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.758004 · Cited by 51
“Meanwhile, stromal, immune, and estimate scores were outputted respectively by the R package ‘estimate’ (35).”
MethodLuo, Y., Zeng, G., & Wu, S. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.01187 · Cited by 55
“Alfred Witjes, J., Lebret, T., Comperat, E. M., Cowan, N. C., De Santis, M., Bruins, H. M., et al. (2017). Updated 2016 EAU Guidelines on Muscleinvasive and Metastatic Bladder Cancer. Eur. Urol. 71, 462–475. doi: 10.1016/j. eururo.2016.06.020 Bader, G. D., and Hogue, C. W. (2003). An automated method for finding molec…”
MethodInfluentialLiu, Z., Liu, L., Jiao, D., Guo, C., Wang, L., Li, Z., Sun, Z., Zhao, Y., & Han, X. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.669694 · Cited by 56
Gui, C., Wei, J., Chen, Y., Fu, L., Tang, Y., Cao, J., Chen, W., & Luo, J. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab173 · Cited by 46
Pei, J., Zhang, C., Yusupu, M., Zhang, C., & Dai, D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.705511 · Cited by 52
“Tumor Immune Microenvironment To investigate the relationships between risk score and TME, the ESTIMATE algorithm was applied to determine immune score, stromal score, ESTIMATE score, and tumor purity of individual patient in the screening and validation cohorts (27).”
MethodPark, Y., Heider, D., & Hauschild, A.-C. (2021) · Cancers · doi:10.3390/cancers13133148 · Cited by 51
“For instance, transcriptome data was analyzed to observe the landscape of immune infiltration [37].”
Liu, Z., Guo, C., Li, J., Xu, H., Lu, T., Wang, L., Liu, L., & Han, X. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.619 · Cited by 63
Yang, J., Zhou, Y., Li, Y., Hu, W., Chen, Y., Chen, S., Ye, G., Chen, Y., Wu, Y., Liu, J., et al. (2022) · Bioengineered · doi:10.1080/21655979.2022.2062537 · Cited by 47
“13) to access the infiltration level of immune cells and stromal cells in ccRCC tissues [30].”
BackgroundDu, X., Qi, Z., Xu, J., Guo, M., zhang, X., Yu, Z., Cao, X., & Xia, J. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13305 · Cited by 47
Glycolysis-Related SLC2A1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy
Zheng, H., Long, G., Zheng, Y., Yang, X., Cai, W., He, S., Qin, X., & Liao, H. (2022) · Cancers · doi:10.3390/cancers14215344 · Cited by 50
Zhu, H., Lin, Y., Lu, D., Wang, S., Liu, Y., Dong, L., Meng, Q., Gao, J., Wang, Y., Song, N., et al. (2023) · National Science Review · doi:10.1093/nsr/nwad167 · Cited by 50
Li, T., Zhang, W., Niu, M., Wu, Y., Deng, X., & Zhou, J. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1342647 · Cited by 53
“Furthermore, we utilized the R package ESTIMATE and deconvo_CIBERSOR method from the R package IOBR to reevaluate the immune in fi ltration score and immune cell in fi ltration in each patient with cervical cancer based on gene expression (37 – 39).”
MethodZhang, P., Yang, Z., Zuo, L., Zhang, G., Zhang, L., Zhang, Z., & Fan, J. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.18408 · Cited by 48
“Furthermore, the specialized functionalities of the ‘estimate’ R package 33 were carefully leveraged to quantify immune scores, stromal scores, and ESTIMATE scores for TCGA-LUAD patients, facilitating a comprehensive assessment of the TME and its potential implications.”
BackgroundConway, C., Graham, J. L., Chengot, P., Daly, C. L., Chalkley, R., Ross, L., Droop, A., Rabbitts, P. H., & Stead, L. F. (2015) · Oncotarget · doi:10.18632/oncotarget.5529 · Cited by 52
“The pathologist immune cell percentage significantly correlates with ESTIMATE immune score for both tissue types but both the correlation coefficient, r, and level of significance is greater for dysplasia versus tumour (dysplasia r:0.72 and p:0.0005 versus tumour r:0.49 and p:0.03).”
MethodInfluentialVarn, F. S., Andrews, E. H., Mullins, D. W., & Cheng, C. (2016) · Nature Communications · doi:10.1038/ncomms10248 · Cited by 50
“For each permutation, a pCLSup/dn is then recalculated by replacing g in equations (1) and (2) with the respective permuted expression vector.”
Follia, L., Ferrero, G., Mandili, G., Beccuti, M., Giordano, D., Spadi, R., Satolli, M. A., Evangelista, A., Katayama, H., Hong, W., et al. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00115 · Cited by 50
“Green (low score) to brown (high score) colors indicate the ESTIMATE score proportional to the estimated stromal/immune component of each tumor sample.”
MethodInfluentialSelecting precise reference normal tissue samples for cancer research using a deep learning approach
Zeng, W. Z. D., Glicksberg, B. S., Li, Y., & Chen, B. (2019) · BMC Medical Genomics · doi:10.1186/s12920-018-0463-6 · Cited by 47
Ding, Q., Dong, S., Wang, R., Zhang, K., Wang, H., Zhou, X., Wang, J., Wong, K., Long, Y., Zhu, S., et al. (2020) · Aging · doi:10.18632/aging.102914 · Cited by 62
“org; repos= rforge, dependencies=TRUE) [24].”
BackgroundHu, B., Yang, X., & Sang, X. (2020) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s272109 · Cited by 57
Metadata
- Authors
- Yoshihara, K., Shahmoradgoli, M., Martínez, E., Vegesna, R., Kim, H., Torres-Garcia, W., Treviño, V., Shen, H., Laird, P. W., Levine, D. A., Carter, S. L., Getz, G., Stemke-Hale, K., Mills, G. B., & Verhaak, R. G. W.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- University of Southern California (US)
- Memorial Sloan Kettering Cancer Center (US)
- Broad Institute (US)
- Corresponding author
- Verhaak, Roel G.W.
- ORCID
- Venue
- Nature Communications
- Published
- 2013-10-11
- Volume
- 4
- Issue
- 1
- Pages
- 2612-2612
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC3826632
- OpenAlex
- W2130430382
- Cited by
- 9,778
- References
- 63
- Citations by year
- 2026: 694 · 2025: 1176 · 2024: 1602 · 2023: 1755 · 2022: 1988 · 2021: 1316 · 2020: 683 · 2019: 223 · 2018: 121 · 2017: 93 · 2016: 53 · 2015: 39 · 2014: 20 · 2013: 2
- FWCI
- 17.01
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Nature Communications (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- University of Texas MD Anderson Cancer Center
- National Cancer Institute (P50CA098258, U24CA143882, CA143883, U24CA143883, P30CA008748, P30CA016672)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Single-cell and spatial transcriptomics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Keywords
- tumor purity, tumor stroma, tumor-infiltrating immune cells, gene expression signatures, tumor microenvironment, DNA copy number, cancer transcriptomics
- MeSH terms
- Algorithms, Cell Separation, Female, Humans, Leukocytes, Neoplasms, Research Design, Sensitivity and Specificity, Software, Gene Library, Genome, Human, Stromal Cells, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, DNA Copy Number Variations, High-Throughput Nucleotide Sequencing, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.